Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHT.L Regulatory News (GHT)

  • There is currently no data for GHT

Board Changes

12 Oct 2020 07:00

RNS Number : 6893B
Gresham Technologies PLC
12 October 2020
 

RNS

 

12 October 2020

Gresham Technologies plc

Wealth of banking and fintech experience to join Board

Gresham Technologies plc (LSE: "GHT", "Gresham" or the "Company"), the leading software and services company that specialises in providing solutions for data integrity and control, banking integration, payments and cash management, announces the appointments of Jenny Knott and Dr. Ruth Wandhöfer as Non-Executive Directors effective from 12 October 2020. These appointments bring a wealth of banking and financial technology experience to the Board in parallel with the recent successful completion of the Chair succession.

Jenny Knott is a qualified accountant and has held roles as Chief Executive, Chief Finance Officer and Chief Operational Officer in banking and in financial technology. She built a reputation as an advocate of technology-enabled modernisation in the financial services sector throughout her executive career, which includes roles at Standard Bank, Nomura Securities and UBS. Whilst CEO of NEX Optimisation, the post-trade, risk and information services business, she was named as one of the top 100 influencers by Financial Technologist in 2018. She is currently Chair of Equiida, the board effectiveness and leadership consultancy, and Non-Executive Director of SimplyHealth.

Dr. Ruth Wandhöfer is a Global Fintech 50 Influencer with considerable experience in the Fintech and RegTech sectors. Her executive career included over a decade at Citi in the transaction services business, including Global Head of Regulatory & Market Strategy for Treasury and Trade Solutions. Prior to this she spent four years as a Policy Adviser on Securities Services and Payments at the European Banking Federation. Following her executive career, she served as Non-Executive Director of the London Stock Exchange and is currently Partner at Gauss Ventures and independent Non-Executive Director at Permanent TSB and Digital Identity Net.

Imogen Joss will continue in her role as Non-Executive Director, Senior Independent Director and Chair of the Remuneration Committee until 31 October 2020 when she will step down from the Board. Jenny Knott will assume responsibility as Chair of the Remuneration Committee and Andy Balchin, currently Non-Executive Director and Chair of the Audit Committee, will assume the role of Senior Independent Non-Executive Director.

Peter Simmonds, Chairman, commented:

"We are delighted to have Jenny and Ruth join the Board. They bring deep experience in global banking and financial technology to the Company at an exciting time as we look to accelerate the Clareti business and further monetise the wealth of IP that the Company has developed and acquired in recent years.

I would like to thank Imogen Joss for her contribution to the Company over the last four years. I would also like to thank my predecessor, Ken Archer, who so ably chaired the business over the last decade and who formally stepped down from the Board at the end of September."

 

Jennifer Catherine Knott, aged 52, does not hold any current directorships in publicly quoted companies. Additionally, she has not held any directorships in publicly quoted companies in the last five years. She has no beneficial interest in the Company as at today's date.

Ruth Wandhöfer, aged 44, is currently director of Permanent TSB Group Holdings plc. and in the last five years, she has been a director of London Stock Exchange Group plc. Her total beneficial interest in the Company is 13,403 Ordinary Shares, representing 0.02% of the Company's total issued share capital as at today's date.

The Company confirms that there are no additional matters requiring disclosure under rule 9.6.13 of the Listing Rules in relation to the appointments of either of the directors.

 

Enquiries

Gresham Technologies plc

+44 (0) 207 653 0200

Ian Manocha

Tom Mullan

N+1 Singer (Financial Adviser and Broker)

+44 (0) 207 496 3000

Shaun Dobson / Iqra Amin (Corporate Finance)

Tom Salvesen (Corporate Broking)

Note to editors

Gresham Technologies plc is a leading software and services company that specialises in providing real-time solutions for data integrity and control, banking integration, payments and cash management. Listed on the main market of the London Stock Exchange (GHT.L) and headquartered in the City of London, its customers include some of the world's largest financial institutions and corporates, all of whom are served locally from offices located in the UK, Europe, North America and Asia Pacific.

Gresham's award-winning Clareti software platform is a highly flexible and scalable platform, available on-site or in the cloud, designed to address today's most challenging financial control, risk management, data governance and regulatory compliance problems. Learn more at www.greshamtech.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZKLFBBBLZFBX
Date   Source Headline
1st Aug 20165:25 pmRNSDirector Declaration
25th Jul 20167:00 amRNSTrading Update
1st Jul 201610:20 amRNSDirector/PDMR Shareholding
27th Jun 201611:23 amRNSDirector/PDMR Shareholding
20th Jun 20161:14 pmRNSDirector/PDMR Shareholding
9th Jun 20167:00 amRNSDirectors' Dealings and Issue of Equity
26th May 20162:01 pmRNSDirector/PDMR Shareholding
16th May 20168:45 amRNSDirector/PDMR Shareholding
28th Apr 201612:36 pmRNSResult of AGM
28th Apr 20167:00 amRNSAGM Statement
7th Apr 20167:00 amRNSPositive start to 2016 with four new CTC customers
31st Mar 20169:09 amRNSDirector/PDMR Shareholding
29th Mar 20168:22 amRNSDirector/PDMR Shareholding
23rd Mar 20162:40 pmRNSNotice of AGM
8th Mar 20167:00 amRNSFinal Results
25th Jan 20167:00 amRNSTrading Update
8th Jan 20169:04 amRNSDirector's Declaration
29th Dec 20157:00 amRNSDirector/PDMR Shareholding
21st Dec 201510:01 amRNSDirector/PDMR Shareholding
16th Dec 201512:51 pmRNSDirector/PDMR Shareholding
15th Dec 20157:00 amRNSRelease of CTC ARM V2.0
30th Nov 20153:54 pmRNSDirector/PDMR Shareholding
18th Nov 20157:00 amRNSHolding(s) in Company
17th Nov 201510:36 amRNSDirector/PDMR Shareholding
12th Nov 201511:13 amRNSIssue of Equity
9th Nov 20153:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20157:00 amRNSCTC Customer Wins
5th Oct 20153:05 pmRNSDirector/PDMR Shareholding
1st Sep 20153:36 pmRNSDirector/PDMR Shareholding
25th Aug 20154:22 pmRNSDirector/PDMR Shareholding
24th Aug 20155:09 pmRNSDirector/PDMR Shareholding
17th Aug 20151:47 pmRNSDirector/PDMR Shareholding
10th Aug 20157:00 amRNSHalf Yearly Report
15th Jul 20157:00 amRNSNotice of Interim Results
29th Jun 20157:00 amRNSCTC North America contract win
1st Jun 20153:05 pmRNSDirectors' Dealings
1st Jun 201512:29 pmRNSGrant of Options
1st Jun 20157:00 amRNSBoard Changes Effective
29th May 20151:30 pmRNSDirector/PDMR Shareholding
18th May 20152:36 pmRNSDirector/PDMR Shareholding
7th May 201512:18 pmRNSResult of AGM
7th May 20157:00 amRNSAGM Statement
27th Apr 201510:07 amRNSDirector/PDMR Shareholding
20th Apr 201511:15 amRNSDirector/PDMR Shareholding
9th Apr 201512:36 pmRNSDirector/PDMR Shareholding
7th Apr 20157:00 amRNSCTC Contract Win
31st Mar 201510:42 amRNSNotice of AGM
24th Mar 20157:01 amRNSProposed Resolution to Purchase Own Shares
24th Mar 20157:00 amRNSAnnual Financial Report
20th Mar 20153:27 pmRNSReduction of Capital Effective

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.